WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (MURA), (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback